Abbott Laboratories vs Abbvie Inc.
ABT vs ABBV — side-by-side comparison from reported financials. ABT leads 7, ABBV leads 5 of 12 comparable metrics.
Abbott Laboratories
ABT · Healthcare
$99.78+1.31%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ABT | ABBV |
|---|---|---|
| Price | $99.78 | $276.43 |
| Market cap | $173B | $488B |
| Revenue (TTM) | $46.6B | $64.4B |
| Revenue growth | +0.5% | +1.8% |
| Net margin | 11.6% | 9.8% |
| Free cash flow | $7.82B | $18.2B |
| Net cash (debt) | ($957M) | ($56.2B) |
| 1-year price return | -25.2% | +19.8% |
| P/E | 31.8 | 77.4 |
| P/E vs own history (cheap-side %) | 44% | 23% |
| Dividend yield | 2.47% | 2.45% |
| Return on equity | 11% | 96% |
| Altman Z-score | 2.84 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 115,000 | 57,000 |
Full résumé-style profiles: ABT CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.